Effect of VP12 and viperistatin on inhibition of collagen receptors-dependent melanoma metastasis

Cancer Biology and Therapy

Volumn 8, Issue 15, 2009, Pages 1507-1516

  Staniszewska, Izabela ^a   Walsh, Erin M ^a   Rothman, Vicki L ^a   Gaathon, Ariel ^b   Tuszynski, George P ^a   Calvete, Juan J ^c   Lazarovici, Philip ^b   Marcinkiewicz, Cezary ^a  

^a Temple University   (United States)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c INSTITUTO DE BIOMEDICINA DE VALENCIA   (Spain)

Author keywords

C lectin type proteins; Disintegrins; Integrins; Melanoma; Metastasis

Indexed keywords

ANTINEOPLASTIC AGENT; COLLAGEN; TUMOR PROTEIN; VERY LATE ACTIVATION ANTIGEN 1; VERY LATE ACTIVATION ANTIGEN 2; VIPER VENOM; VP121 PROTEIN, VIPERA PALEASTINAE;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; CELL ADHESION; CELL STRAIN K 562; CHEMISTRY; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG SCREENING; EXPERIMENTAL MELANOMA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ION EXCHANGE CHROMATOGRAPHY; ISOLATION AND PURIFICATION; LUNG TUMOR; MELANOMA; METABOLISM; METASTASIS; MOLECULAR GENETICS; MOUSE; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHYSIOLOGY; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY; SNAKE; TUMOR CELL LINE;

AMINO ACID SEQUENCE; ANIMALS; ANTINEOPLASTIC AGENTS; CELL ADHESION; CELL LINE, TUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, ION EXCHANGE; COLLAGEN; CONSERVED SEQUENCE; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; INTEGRIN ALPHA1BETA1; INTEGRIN ALPHA2BETA1; K562 CELLS; LUNG NEOPLASMS; MELANOMA; MELANOMA, EXPERIMENTAL; MICE; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; VIPER VENOMS; VIPERIDAE;

EID: 70349600735     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.8.15.8999     Document Type: Article

References (41)

1. Nguyen TH. Mechanisms of metastasis. Clin Dermatol 2004; 22:209-216
2. Sheppard D. In vivo functions of integrins: lessons from null mutations in mice. Matrix Biol 2000; 19:203-209
3. Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell 2002; 110:673-687
4. Dickeson SK, Santoro SA. Ligand recognition by the I domain-containing integrins. Cell Mol Life Sci 1998; 54:556-566
5. Seftor RE, Seftor EA, Hendrix MJ. Molecular role(s) for integrins in human melanoma invasion. Cancer Metastasis Rev 1999; 18:359-375
6. Kuphal S, Bauer R, Bosserhoff AK. Integrin signaling in malignant melanoma. Cancer Metastasis Rev 2005; 24:195-222.
7. Kramer RH, Marks N. Identification of integrin collagen receptors on human melanoma cells. J Biol Chem 1989; 264:4684-4688 (Pubitemid 19081377)
8. Danen EH, van Muijen GN, van de Wiel-van Kemenade E, Jansen KF, Ruiter DJ, Figdor CG. Regulation of integrin-mediated adhesion to laminin and collagen in human melanocytes and in non-metastatic and highly metastatic human melanoma cells. Int J Cancer 1993; 54:315-321
9. Friedl P, Maaser K, Klein CE, Niggemann B, Krohne G, Zänker KS. Migration of highly aggressive MV3 melanoma cells in 3-dimensional collagen lattices results in local matrix reorganization and shedding of alpha2 and beta1 integrins and CD44. Cancer Res 1997; 57:2061-2070 (Pubitemid 27209742)
10. 2+ as a potential downregulator of alpha2beta1-integrin-mediated A2058 tumor cell migration to type IV collagen. Am J Physiol Cell Physiol 2001; 281:106-113
11. Klein CE, Steinmayer T, Kaufmann D, Weber L, Bröcker EB. Identification of a melanoma progression antigen as integrin VLA-2. J Invest Dermatol 1991; 96:281-284
12. Schadendorf D, Gawlik C, Haney U, Ostmeier H, Suter L, Czarnetzki BM. Tumour progression and metastatic behaviour in vivo correlates with integrin expression on melanocytic tumours. J Pathol 1993; 170:429-434 (Pubitemid 23253022)
13. Schadendorf D, Fichtner I, Makki A, Alijagic S, Küpper M, Mrowietz U, et al. Metastatic potential of human melanoma cells in nude mice-characterisation of phenotype, cytokine secretion and tumour-associated antigens. Br J Cancer 1996; 74:194-199 (Pubitemid 126732894)
14. Vuoristo M, Vihinen P, Vlaykova T, Nylund C, Heino J, Pyrhönen S. Increased gene expression levels of collagen receptor integrins are associated with decreased survival parameters in patients with advanced melanoma. Melanoma Res 2007; 17:215-223 (Pubitemid 47067079)
15. Koh DC, Armugam A, Jeyaseelan K. Snake venom components and their applications in biomedicine. Cell Mol Life Sci 2006; 63:30-41. (Pubitemid 46072306)
16. Fox JW, Serrano SM. Approaching the golden age of natural product pharmaceuticals from venom libraries: an overview of toxins and toxin-derivatives currently involved in therapeutic or diagnostic applications. Curr Pharm Des 2007; 13:2927-2934
17. Morita T. Structure-function relationships of C-type lectin-related proteins. Pathophysiol Haemost Thromb 2005; 34:156-159 (Pubitemid 43760345)
18. Marcinkiewicz C, Lobb RR, Marcinkiewicz MM, Daniel JL, Smith JB, Dangelmaier C, et al. Isolation and characterization of EMS16, a C-lectin type protein from Echis multisquamatus venom, a potent and selective inhibitor of the alpha2beta1 integrin. Biochemistry 2000; 39:9859-9867
19. Horii K, Okuda D, Morita T, Mizuno H. Crystal structure of EMS16 in complex with the integrin alpha2-I domain. J Mol Biol 2004; 341:519-527 (Pubitemid 38992304)
20. Niewiarowski S, McLane MA, Kloczewiak M, Stewart GJ. Disintegrins and other naturally occurring antagonists of platelet fibrinogen receptors. Semin Hematol 1994; 31:289-300. (Pubitemid 24325181)
21. Marcinkiewicz C. Functional Characteristic of snake venom disintegrins: Potential therapeutic implication. Curr Pharm Design 2005; 11:815-827 (Pubitemid 40331033)
22. Marcinkiewicz C, Weinreb PH, Calvete JJ, Kisiel DG, Mousa SA, Tuszynski GP, et al. Obtustatin: a potent selective inhibitor of alpha1beta1 integrin in vitro and angiogenesis in vivo. Cancer Res 2003; 63:2020-2023 (Pubitemid 36538600)
23. Kisiel DG, Calvete JJ, Katzhendler J, Fertala A, Lazarovici P, Marcinkiewicz C. Structural determinants of the selectivity of KTS-disintegrins for the α1β1 integrin. FEBS Lett 2004; 577:478-482 (Pubitemid 39535335)
24. Sanz L, Chen RQ, Perez A, Hilario R, Juarez P, Marcinkiewicz C, et al. cDNA cloning and functional expression of jerdostatin, a novel RTS-disintegrin from Trimeresurus jerdonii and a specific antagonist of the alpha1beta1 integrin. J Biol Chem 2005; 280:40714-40722
25. Olfa KZ, José L, Salma D, Amine B, Najet SA, Nicolas A, et al. Lebestatin, a disintegrin from Macrovipera venom, inhibits integrin-mediated cell adhesion, migration and angiogenesis. Lab Invest 2005; 85:1507-1516 (Pubitemid 41662335)
26. Bazan-Socha S, Kisiel DG, Young B, Theakston RDG, Calvete JJ, Sheppard D, et al. Structural requirements of MLD-containing disintegrins for functional interaction with α4β1 and α9β1 integrins. Biochemistry 2004; 43:1639-1647 (Pubitemid 38200570)
27. Brown MC, Staniszewska I, Del Valle L, Tuszynski GP, Marcinkiewicz C. Angiostatic activity of obtustatin as α1β1 integrin inhibitor in experimental melanoma growth. Int J Cancer 2008; 123:2195-2203
28. Felding-Habermann B, Fransvea E, O'Toole TE, Manzuk L, Faha B, Hensler M. Involvement of tumor cell integrin alphavbeta3 in hematogenous metastasis of human melanoma cells. Clin Exp Metastasis 2002; 19:427-436 (Pubitemid 34876210)
29. van Muijen GNP, Jansen KFJ, Cornelissen IMHA, Smeets DFCM, Beck JLM, Ruiter DJ. Establishment and characterization of human melanoma cell line (MV3) which is highly metastatic in nude mice. In J Cancer 1991; 48:85-91.
30. Hardan I, Weiss L, Hershkoviz R, Greenspoon N, Alon R, Cahalon L, et al. Inhibition of metastatic cell colonization in murine lungs and tumor-induced morbidity by nonpeptidic Arg-Gly-Asp mimetics. Int J Cancer 1993; 55:1023-1028 (Pubitemid 24005351)
31. Kang IC, Kim DS, Jang Y, Chung KH. Suppressive mechanism of salmosin, a novel disintegrin in B16 melanoma cell metastasis. Biochem Biophys Res Commun 2000; 275:169-173 (Pubitemid 30663647)
32. Ramos OH, Kauskot A, Cominetti MR, Bechyne I, Salla Pontes CL, Chareyre F, et al. A novel alpha(v)beta(3)-blocking disintegrin containing the RGD motive, DisBa-01, inhibits bFGF-induced angiogenesis and melanoma metastasis. Clin Exp Metastasis 2008; 25:53-64.
33. Qian F, Valux DL, Weissman IL. Expression of integrin α4β1 on melanoma cells can inhibit invasive stage of metastasis formation. Cell 1994; 77:335-347 (Pubitemid 2084224)
34. Cardones AR, Murakami T, Hwang ST. CXCR4 enhances adhesion of B16 tumor cells to endothelial cells in vitro and in vivo via beta(1) integrin. Cancer Res 2003; 63:6751-6757
35. Calvete JJ, Marcinkiewicz C, Sanz L. KTS and RTS-disntegrins: Anti-angiogenic viper venom peptides specifically targeting α1β1 integrin. Curr Pharm Des 2007; 13:2853-2860
36. Lutterotti A, Martin R. Getting specific: monoclonal antibodies in multiple sclerosis. Lancet Neurol 2008; 7:538-547 (Pubitemid 351657494)
37. Senger D, Perruzzi CA, Streit M, Koteliansky VE, de Fougerolles AR, Detmar M. The alpha(1)beta(1) and alpha(2)beta(1) integrins provide critical support for vascular endothelial growth factor signaling, endothelial cell migration and tumor angiogenesis. Am J Pathol 2002; 160:195-204.
38. Marcinkiewicz C, Rosenthal LA, Mosser DM, Kunicki TJ, Niewiarowski S. Immunological characterization of eristostatin and echistatin binding sites on αIIbβ3 and αvβ3 integrins. Biochem J 1996; 317:817-852 (Pubitemid 26308256)
39. Peng M, Holt JC, Niewiarowski S. Isolation, characterization and amino acid sequence of echicetin beta subunit, a specific inhibitor of von Willebrand factor and thrombin interaction with glycoprotein Ib. Biochem Biophys Res Commun 1994; 205:68-72. (Pubitemid 24381591)
40. Usami Y, Fujimura Y, Suzuki M, Ozeki Y, Nishio K, Fukui H, et al. Primary structure of two-chain botrocetin, a von Willebrand factor modulator purified from the venom of Bothrops jararaca. Proc Natl Acad Sci USA 1993; 90:928-932 (Pubitemid 23053923)
41. Horii K, Okuda D, Morita T, Mizuno H. Structural characterization of EMS16, an antagonist of collagen receptor (GPIa/IIa) from the venom of Echis multisquamatus. Biochemistry 2003; 42:12497-12502 (Pubitemid 37337539)